CAREDX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $11.60 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2025-02-28
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2023-12-31 was $2.80M.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2023-09-30 was $3.20M.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-06-30 was -$100.00K.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-03-31 was $400.00K.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $11.60M, a 36.96% decline from fiscal 2023.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $18.40M, a 73.58% increase from fiscal 2022.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $10.60M, a 9.40% decline from fiscal 2021.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2021 was $11.70M, a 30.00% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2024-12-31 | $11.60M 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $6.00M derived: sum of 2 quarters · filed 2024-02-28 | $18.40M 10-K · filed 2024-02-28 | |
| 2023-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $15.60M 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | $12.40M 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $10.60M 10-K · filed 2023-02-27 | |||
| 2021-12-31 | $11.70M 10-K · filed 2022-02-24 | |||
| 2020-12-31 | $9.00M 10-K · filed 2021-02-24 | |||
| 2019-12-31 | $4.00M 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $1.20M 10-K · filed 2019-03-06 | |||
| 2017-12-31 | $700.00K 10-K · filed 2018-03-22 | |||
| 2017-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $300.00K 10-Q · filed 2017-08-11 | ||
| 2017-03-31 | $400.00K 10-Q · filed 2017-06-09 | |||
| 2016-12-31 | $1.10M 10-K · filed 2017-04-21 | |||
| 2015-12-31 | $1.10M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |